AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Lebrikizumab monotherapy improves quality of life through improvement in itch and sleep: Results from two Phase 3 trials in patients with moderate-to-severe atopic dermatitis

Gil Yosipovitch,Marjolein de Bruin-Weller,Marni Wiseman,Jesper Elberling,Jan Gutermuth,Evangeline Pierce,Sonia Montmayeur,Yuxin Ding,Emily Yang,Sarah Chisolm

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY（2023）

引用 0|浏览9
暂无评分
关键词
lebrikizumab monotherapy,moderate-to-severe
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要